News
03-09-2017, 05:24 PM
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have designed two new drug candidates to target prostate and triple negative breast cancers.
More... (http://www.news-medical.net/news/20170309/TSRI-researchers-develop-new-drug-candidates-to-target-prostate-and-triple-negative-breast-cancers.aspx)
More... (http://www.news-medical.net/news/20170309/TSRI-researchers-develop-new-drug-candidates-to-target-prostate-and-triple-negative-breast-cancers.aspx)